-
Evaluation of the Article 51 VIGIE-AGE Experiment: A Significant Impact on Hospitalizations Resulting in Reduced Total Expenditure
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review to Identify Potential Risk Factors and Causative Organisms for Neonatal Sepsis in Indian Neonates
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Ustekinumab Against Vedolizumab Among Inflammatory Bowel Disease Patients With Extra-intestinal Manifestations in Egypt
Sep 9, 2025, 16:22 PM -
Pulmonary Nodule (PN)-Related and Lung Cancer-Related Workup Costs Within the Two-Year Period After Diagnosis of a PN in the United States
Sep 9, 2025, 16:22 PM -
Value of Patient-Reported Outcomes Data in Food and Drug Administration Labeling of Oncology Drugs to Payers in the United States
Sep 9, 2025, 16:22 PM -
Economic Burden and Healthcare Resource Utilization of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Germany: A Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Enhancing Patient Experience of Subcutaneous Administration in Oncology: Development of a Dedicated Patient-Reported Experience Measure (PREM) Questionnaire Based on a Structured and Collaborative Approach
Sep 9, 2025, 16:22 PM -
Defining Patient-Centered Outcomes in CAR-T-cell Therapy: Is There a Need for a Patient-Informed CAR-T PROM?
Sep 9, 2025, 16:22 PM -
Comparing Risk of Bias Assessment Requirements Between the EU JCA and European HTA Agencies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Minocycline Intravenous for the Treatment of Serious Infections Due to Multidrug-Resistant Acinetobacter baumannii in Jordan
Sep 9, 2025, 16:22 PM -
Nephrotoxicity of Antisense Oligonucleotide Therapies in Duchenne Muscular Dystrophy: A Warning or a Challenge?
Sep 9, 2025, 16:22 PM -
Evaluating the Role of Disease-Specific Patient-Reported Outcomes in HTA Submissions for Rare Conditions: A Comparative Case Study of Narcolepsy and Phenylketonuria
Sep 9, 2025, 16:22 PM -
Requirements for Payer Recognition of Disease-Modifying Effect in New Drug Launches
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of WIC Eligibility Extension in Preventing Maternal Postpartum Depression: US Payers’ Perspective
Sep 9, 2025, 16:22 PM -
Exploring Evidence Gaps in National Institute for Health and Care Excellence Early Value Assessments
Sep 9, 2025, 16:22 PM -
Evidence Strategy Starts Early: Integrating HTA Needs Through PICO Simulation in Metastatic Castration-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
Navigating Reimbursement Challenges for Pharmacological Interventions in Celiac Disease: Lessons From Analogous Conditions
Sep 9, 2025, 16:22 PM -
Estimating Healthcare Resource Use Associated With the Treatment of Phenylketonuria in the United States
Sep 9, 2025, 16:22 PM -
Global Pricing Meets Domestic Policy: Analyzing the Financial Impact of the Most-Favored Nation Approach on the United States Medicine Prices
Sep 9, 2025, 16:22 PM -
Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Lung Cancer Patients Using Machine Learning
Sep 9, 2025, 16:22 PM
